HELEN MCLEMORE: Open Payments
NPI 1457897654 · MONTGOMERY, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,012 in 144 payments from 17 companies in 2025. Trend: 2023 $3,054 · 2024 $3,373 · 2025 $3,012
Food & beverage: $2,927Education: $85
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 36 | $559 |
| UCB, Inc. | 14 | $364 |
| GENZYME CORPORATION | 10 | $309 |
| Janssen Biotech, Inc. | 20 | $302 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 11 | $300 |
| Novartis Pharmaceuticals Corporation | 17 | $270 |
| Regeneron Healthcare Solutions, Inc. | 8 | $205 |
| PFIZER INC. | 7 | $121 |
| Organon LLC | 2 | $110 |
| Incyte Corporation | 4 | $99 |
Products named: DUPIXENT, RINVOQ, Bimzelx, TREMFYA, SKYRIZI, ILUMYA, COSENTYX, CIBINQO.
Industry payments across AL — which companies pay providers there.
